Physician profile
Marc New
NPI 1831170612
$3,031.43
in general payments reported to CMS, 2019-2025
16 companies · $1,043 in 2025
The $1,043 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $221 · 2021: $295 · 2023: $1,212 · 2025: $1,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,145 · Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,145.40 |
| Food and Beverage | $109.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,372.57 | 2019-2025 | Exalt Model D, Spyglass, Overstitch Endoscopic Suturing System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $235.50 | 2019-2021 | |
| Abbvie INC. | $118.30 | 2019-2021 | |
| Gilead Sciences, INC. | $45.15 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $43.93 | 2021 | |
| Braintree Laboratories, INC. | $36.36 | 2021 | |
| Qol Medical, LLC | $32.73 | 2020-2021 | |
| Redhill Biopharma INC. | $29.80 | 2020-2021 | |
| Intercept Pharmaceuticals, INC. | $23.40 | 2019-2020 | |
| Pfizer INC. | $16.92 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.85 | 2020 | |
| Shionogi INC | $14.46 | 2019 | |
| Allergan, INC. | $12.39 | 2020 | |
| Merck Sharp & Dohme LLC | $11.65 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $11.31 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Romark Laboratories, Lc | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc New listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.